BioStem Technologies Unveils Innovations at SAWC Fall Meeting
BioStem Technologies Showcases BioREtain® Technology
BioStem Technologies, Inc. (OTC: BSEM), a prominent player in the MedTech sector, is excited to announce its participation at the Symposium for Advanced Wound Care (SAWC) Fall Meeting. This event serves as a prestigious platform where healthcare professionals gather to enhance their understanding of chronic wound care and explore groundbreaking innovations.
Collaborative Efforts with Venture Medical
This year, BioStem is collaborating with Venture Medical, LLC, showcasing a dynamic partnership aimed at revolutionizing chronic wound care management. Their joint exhibit will be highlighting the synergistic benefits of BioStem's placental-derived allografts in conjunction with the innovative Venture OneView™ platform, designed to streamline patient management when dealing with skin substitutes for chronic wounds.
Highlighting Premier Products
The BioStem Allograft Portfolio
At the meeting, visitors will learn about BioStem's flagship products: AmnioWrap2 and Vendaje AC. Exclusively available through Venture Medical, these exceptional treatment options enhance patient outcomes while ensuring compliance with care standards.
Interactive Booth Schedule
The BioStem-Venture booth will feature a schedule allowing attendees to engage with experts, exchanging views on optimal practices for chronic wound care. Key presentations will include:
- Discussing Myths in Wound Care by Laura Raty-Kerstetter, FNP-C: Friday, 1:00 PM – 2:00 PM
- Essentials of Mobile Wound Care by Louis Heuser, MD: Saturday, 12:30 PM – 1:30 PM
Sponsored Breakfast Symposium
A highlight of the event will be a sponsored breakfast symposium titled 'Navigating the Future of Wound Care,' moderated by Dr. Michael Desvigne. Participants can expect rich discussions concerning real-world clinical evidence, essential factors for choosing the right allograft, and insights into successfully operating mobile wound care practices.
Scientific Contributions through Posters
Accepted Clinical and Scientific Research
This year, BioStem is proud to present three of its clinical and scientific research posters at the event:
Key Presentations
- A Simple Comparison of Real-World Pressure Ulcer Data
- A Direct Comparison of Processing Methods for Placental Tissue Allografts
- A Comparison of Sterilization Methods for Dehydrated Birth Tissue
The Innovative BioREtain® Method
BioStem's proprietary BioREtain® technology stands at the forefront of their offerings. This unique six-step processing method is designed to preserve the natural properties of the placental tissue while retaining its structural integrity. This approach ensures that the amniotic tissue's key components remain intact, critical for effective wound treatment and management.
About BioStem Technologies, Inc.
As a pioneer in leveraging perinatal tissue's properties, BioStem Technologies focuses on developing and manufacturing allografts aimed at transforming lives. With a commitment to quality, their innovative BioREtain® processing method is supported by the latest advancements in wound care research. Their manufacturing practices are aligned with Good Tissue Practices (cGTP) and Good Manufacturing Processes (cGMP), ensuring safety and efficacy in all products.
Contact Information
To learn more about BioStem Technologies, visit www.biostemtechnologies.com or connect through social media on X and LinkedIn. For inquiries, you can email info@biostemtech.com.
Frequently Asked Questions
What is BioStem Technologies known for?
BioStem Technologies is recognized for developing and commercializing placental-derived products that enhance chronic wound care management.
What is the BioREtain® technology?
BioREtain® is a proprietary processing method that preserves the native properties of placental tissue for effective wound treatment.
Where is the SAWC Fall Meeting taking place?
The SAWC Fall Meeting occurs in Las Vegas and serves as a hub for wound care professionals to share insights and advancements.
Who are the partners for BioStem at SAWC?
BioStem Technologies is co-exhibiting with Venture Medical, highlighting their collaborative approach to improving chronic wound care solutions.
How can I find out more about BioStem's products?
For more information, visit their official website or follow their social media channels.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
